A Randomized Phase II Study of Two Schedules of Decitabine for Frontline Therapy of Older or Unfit Patients With Acute Myeloid Leukemia (AML)
Phase of Trial: Phase II
Latest Information Update: 14 Jul 2017
At a glance
- Drugs Decitabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Pharmacogenomic; Therapeutic Use
- 06 Jul 2017 Planned primary completion date changed from 1 Feb 2018 to 1 Feb 2019.
- 01 Apr 2016 Planned primary completion date changed from 1 Feb 2017 to 1 Feb 2018, according to ClinicalTrials.gov record.
- 12 Feb 2013 New trial record